Company intelligence / Profile preview

Jiangsu Pharmaceutical

Jiangsu, China

Ownership: Private
Employees: ~600
Development stage: Other

Overview

Jiangsu Pharmaceutical Co., Ltd. integrates traditional Chinese medicine and Western pharmaceutical generics, producing a range of formulations including tablets, capsules, granules, syrups, and decoctions. The company's products include several that have passed Chinese generic drug consistency evaluations. Its notable traditional Chinese medicine products, such as Weisu Granules and Diling Weitong Granules for stomach pain, are clinically endorsed and target digestive and pain-related indications.

Therapeutic areas: NeurologyCardiovascular
Modalities: Small moleculeTraditional Chinese medicine
Industry: Biotech

Drug pipeline

3 assets

Longshen Tonic Ointment

Unknown

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Jiangsu Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiangsu Pharmaceutical.

Explore the full profile